To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene C19orf22TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
281 supporting clones for gene C19orf22 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
CR614472 Neuroblastoma Cot 50-normalized .a 1 to 1786 1 to 1786 exact tiling clone,   1786/1786
(100 %)
0 diff
(100 %id)
BM560472 brain, medulla .a 5 to 866 1 to 868       868/1073
(80 %)
39 diff
(96.4 %id)
CR596729 Neuroblastoma Cot 10-normalized .a 7 to 1786 1 to 1780       1780/1780
(100 %)
0 diff
(100 %id)
NM_138774.3   .a 7 to 1815 1 to 1809   RefSeq, AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 1809/1809
(100 %)
0 diff
(100 %id)
AL522494 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .a 8 to 874 1 to 861   fully sequenced,   861/861
(100 %)
18 diff
(98.0 %id)
BI916828 brain .a 10 to 702 1 to 713       689/715
(96 %)
44 diff
(93.9 %id)
BQ048918 embryonal carcinoma, cell line, testis .a 10 to 540 1 to 531       531/1191
(44 %)
13 diff
(99.0 %id)
TI_57239618   .a 10 to 702 27 to 739       687/741
(92 %)
40 diff
(94.7 %id)
BM553385 amelanotic melanoma, cell line, skin .a 20 to 1003 1 to 992       992/1134
(87 %)
21 diff
(98.2 %id)
CR614470 fetal brain .a 21 to 1772 1 to 1752       1752/1752
(100 %)
0 diff
(100 %id)
CR622307 Placenta Cot 25-normalized .a 21 to 1783 1 to 1763       1763/1763
(100 %)
0 diff
(100 %id)
AL531013 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .a 21 to 951 20 to 948   fully sequenced,   929/948
(97 %)
9 diff
(99.1 %id)
AL542910 placenta .a 21 to 859 1 to 839       839/839
(100 %)
7 diff
(99.2 %id)
AL536245 brain, fetal brain .a 21 to 948 1 to 927   fully sequenced,   927/927
(100 %)
7 diff
(99.3 %id)
BX397162 Placenta Cot 25-normalized .a 21 to 853 1 to 824   fully sequenced,   824/824
(100 %)
10 diff
(98.8 %id)
DB471490 hippocampus .a 24 to 516 1 to 493       493/493
(100 %)
6 diff
(98.8 %id)
BX385567   .a 25 to 1011 1 to 971       971/1013
(95 %)
31 diff
(97.0 %id)
CR619216 B cells (Ramos cell line) Cot 25-normalized .a 26 to 1641 1 to 1616       1616/1616
(100 %)
0 diff
(100 %id)
AL516278 brain, neuroblastoma, neuroblastoma cells .a 26 to 870 1 to 843       843/843
(100 %)
13 diff
(98.5 %id)
CR616662 Placenta Cot 25-normalized .a 27 to 1749 1 to 1723       1723/1723
(100 %)
0 diff
(100 %id)
BX396097 Placenta Cot 25-normalized .a 27 to 977 1 to 943   fully sequenced,   943/943
(100 %)
3 diff
(99.7 %id)
TI_57244042   .a 27 to 721 29 to 751       721/993
(72 %)
40 diff
(96.0 %id)
BG326216 Kidney, renal cell adenocarcinoma .a 28 to 636 1 to 609       609/773
(78 %)
5 diff
(99.4 %id)
CD243820 testis .a 28 to 718 1 to 694       694/946
(73 %)
10 diff
(99.0 %id)
CN373363 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 29 to 521 1 to 493       493/493
(100 %)
0 diff
(100 %id)
CR735254 carcinoma, cell line, Prostate .a 29 to 522 52 to 547       496/547
(90 %)
9 diff
(98.4 %id)
BM544612 brain, hippocampus .a 29 to 1003 1 to 985       985/1003
(98 %)
27 diff
(97.4 %id)
BQ276298 carcinoma, cell line, Prostate .a 29 to 718 11 to 705       695/1108
(62 %)
16 diff
(98.6 %id)
CR606082 HeLa cells Cot 25-normalized .a 30 to 1811 1 to 1782       1782/1782
(100 %)
0 diff
(100 %id)
BX363157   .a 30 to 978 1 to 934   fully sequenced,   934/934
(100 %)
13 diff
(98.7 %id)
BI522479 brain .a 30 to 703 1 to 673       673/673
(100 %)
5 diff
(99.3 %id)
BI917358 brain .a 30 to 786 1 to 769       769/771
(99 %)
21 diff
(97.3 %id)
TI_44185119   .a 30 to 703 28 to 700       673/700
(96 %)
10 diff
(98.6 %id)
TI_57244648   .a 30 to 786 33 to 801       769/803
(95 %)
20 diff
(97.6 %id)
AL561021 B cells from Burkitt lymphoma .a 31 to 720 1 to 690       690/690
(100 %)
14 diff
(98.0 %id)
BG476194 melanotic melanoma, skin .a 31 to 957 1 to 921       921/967
(95 %)
34 diff
(96.5 %id)
BG478672 melanotic melanoma, skin .a 31 to 779 1 to 755       755/917
(82 %)
18 diff
(98.1 %id)
BM920814 pooled brain, lung, testis .a 31 to 917 20 to 912       893/1048
(85 %)
21 diff
(98.0 %id)
CB215805 normal endometrium, late proliferativephase, cycle day 13, uterus .a 31 to 647 1 to 617       617/617
(100 %)
0 diff
(100 %id)
BC012775 Skin, melanotic melanoma. .a 32 to 1815 1 to 1784   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 1784/1784
(100 %)
0 diff
(100 %id)
BE302601 melanotic melanoma, skin .a 34 to 350 1 to 317     Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 317/317
(100 %)
2 diff
(99.4 %id)
BE410740 choriocarcinoma, placenta .a 34 to 717 1 to 686       686/693
(98 %)
16 diff
(97.7 %id)
CR985457 T-Lymphocytes .a 35 to 839 1 to 808       808/813
(99 %)
3 diff
(99.7 %id)
BI914855 brain .a 36 to 721 2 to 716       713/958
(74 %)
40 diff
(95.9 %id)
AL550268 placenta, Placenta Cot 25-normalized .a 37 to 786 1 to 747   fully sequenced,   747/747
(100 %)
36 diff
(95.2 %id)
CN373365 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 41 to 392 18 to 370       353/370
(95 %)
7 diff
(98.2 %id)
CR990910 T-Lymphocytes .a 41 to 863 1 to 823       823/824
(99 %)
5 diff
(99.4 %id)
CR597374 Placenta Cot 25-normalized .a 42 to 1783 1 to 1742       1742/1742
(100 %)
0 diff
(100 %id)
BX395770 Placenta Cot 25-normalized .a 42 to 914 1 to 853   fully sequenced,   853/853
(100 %)
10 diff
(98.9 %id)
BM913715 astrocytoma grade IV, cell line, brain .a 42 to 558 1 to 519       519/1231
(42 %)
14 diff
(98.9 %id)
TI_57198585   .a 43 to 922 32 to 961       821/965
(85 %)
80 diff
(91.8 %id)
TI_57234789   .a 43 to 785 24 to 767       744/768
(96 %)
8 diff
(99.0 %id)
DB481600 hippocampus .a 44 to 518 1 to 475       475/475
(100 %)
1 diff
(99.8 %id)
BG764350 melanotic melanoma, high MDR (cell line), skin .a 48 to 780 1 to 752       743/812
(91 %)
43 diff
(94.8 %id)
BI907744 leukocyte .a 48 to 785 1 to 738       738/739
(99 %)
2 diff
(99.8 %id)
CR975861 T-Lymphocytes .a 49 to 751 1 to 703       703/703
(100 %)
0 diff
(100 %id)
BE389255 endometrium, adenocarcinoma cell line, uterus .a 50 to 672 1 to 626       628/626
(100 %)
12 diff
(98.1 %id)
BM808320 ovary (pool of 3) .a 50 to 612 3 to 567       565/1180
(47 %)
17 diff
(98.6 %id)
CR989355 T-Lymphocytes .a 50 to 656 1 to 608       608/608
(100 %)
1 diff
(99.9 %id)
CN373360 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 51 to 770 1 to 721       721/721
(100 %)
4 diff
(99.5 %id)
CR599301 Neuroblastoma Cot 25-normalized .a 51 to 1785 1 to 1735       1735/1735
(100 %)
0 diff
(100 %id)
BX394592 Neuroblastoma Cot 25-normalized .a 51 to 1006 1 to 934   fully sequenced,   934/934
(100 %)
3 diff
(99.7 %id)
BE389974 endometrium, adenocarcinoma cell line, uterus .a 51 to 615 1 to 566       566/567
(99 %)
2 diff
(99.7 %id)
BE727072 melanotic melanoma, skin .a 51 to 901 1 to 852       852/1127
(75 %)
31 diff
(97.3 %id)
BE729499 melanotic melanoma, skin .a 51 to 859 1 to 811   available from MGC,   813/1090
(74 %)
20 diff
(98.2 %id)
BE387850 endometrium, adenocarcinoma cell line, uterus .a 52 to 662 1 to 619       620/696
(89 %)
17 diff
(97.6 %id)
BE388900 endometrium, adenocarcinoma cell line, uterus .a 52 to 497 1 to 452       452/452
(100 %)
7 diff
(98.5 %id)
BM479031 melanotic melanoma, skin .a 52 to 696 1 to 646       646/1161
(55 %)
7 diff
(99.4 %id)
BI523543 brain .a 53 to 898 1 to 844   fully sequenced,   844/844
(100 %)
12 diff
(98.6 %id)
TI_57183299   .a 53 to 699 28 to 684       657/686
(95 %)
22 diff
(96.8 %id)
TI_44185177   .a 53 to 898 1 to 844   fully sequenced,   844/844
(100 %)
12 diff
(98.6 %id)
BX387284 Placenta Cot 25-normalized .a 56 to 932 1 to 860       860/863
(99 %)
26 diff
(97.0 %id)
CR617180 Neuroblastoma Cot 10-normalized .a 59 to 1794 1 to 1736       1736/1736
(100 %)
0 diff
(100 %id)
CR617940 B cells (Ramos cell line) .a 59 to 1786 1 to 1728       1728/1728
(100 %)
0 diff
(100 %id)
AL522459 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .a 59 to 908 1 to 849   fully sequenced,   849/849
(100 %)
3 diff
(99.7 %id)
AL524977 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 59 to 698 1 to 639       639/639
(100 %)
1 diff
(99.9 %id)
AL559722 B cells (Ramos cell line), B cells from Burkitt lymphoma .a 59 to 926 1 to 865   fully sequenced,   865/865
(100 %)
3 diff
(99.7 %id)
BI769880 pooled lung and spleen .a 59 to 699 1 to 651       651/653
(99 %)
17 diff
(97.4 %id)
BI820024 pooled brain, lung, testis .a 60 to 932 1 to 867       867/868
(99 %)
15 diff
(98.3 %id)
TI_57199734   .a 60 to 932 70 to 936       867/937
(92 %)
21 diff
(97.8 %id)
BM545400 brain, hippocampus .a 67 to 637 32 to 604       573/1196
(47 %)
20 diff
(98.4 %id)
BQ721313 sympathetic trunk .a 69 to 719 1 to 650       650/1032
(62 %)
12 diff
(98.9 %id)
CN373364 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 72 to 867 1 to 796       796/796
(100 %)
0 diff
(100 %id)
BI908462 leukocyte .a 74 to 794 1 to 721       721/722
(99 %)
1 diff
(99.9 %id)
BI833296 pooled pancreas and spleen .a 74 to 686 1 to 617       617/617
(100 %)
6 diff
(99.1 %id)
TI_57236766   .a 74 to 794 67 to 787       721/788
(91 %)
7 diff
(99.2 %id)
TI_57165833   .a 74 to 686 32 to 648       617/648
(95 %)
12 diff
(98.2 %id)
BI836156 pooled pancreas and spleen .a 78 to 788 1 to 727       727/727
(100 %)
29 diff
(96.1 %id)
TI_57165001   .a 78 to 788 32 to 758       727/758
(95 %)
28 diff
(96.4 %id)
CN373362 embryonic stem cells, cell lines H1, H7, andH9 .a 80 to 546 1 to 467       467/467
(100 %)
5 diff
(99.0 %id)
TI_57237210   .a 80 to 665 62 to 648       587/648
(90 %)
8 diff
(98.8 %id)
CR592767 fetal brain .a 81 to 1717 1 to 1637       1637/1637
(100 %)
0 diff
(100 %id)
AL566238 brain, fetal brain .a 81 to 951 1 to 868   fully sequenced,   868/868
(100 %)
4 diff
(99.6 %id)
T08450   .a 82 to 341 1 to 260       260/260
(100 %)
0 diff
(100 %id)
BI908540 leukocyte .a 86 to 665 1 to 581       581/581
(100 %)
3 diff
(99.5 %id)
CR608111 T cells (Jurkat cell line) Cot10-normalized .a 93 to 1785 1 to 1693       1693/1693
(100 %)
0 diff
(100 %id)
AL558640 T cells from T cell leukemia .a 93 to 997 1 to 905   fully sequenced,   905/905
(100 %)
6 diff
(99.4 %id)
TI_154188236   .a 94 to 636 123 to 665       543/945
(57 %)
23 diff
(97.6 %id)
BI767714 pooled lung and spleen .a 95 to 890 1 to 797       797/805
(99 %)
14 diff
(98.3 %id)
BI909375 leukocyte .a 95 to 692 1 to 598       598/598
(100 %)
3 diff
(99.5 %id)
TI_57183721   .a 95 to 890 67 to 863       797/871
(91 %)
19 diff
(97.9 %id)
TI_57233949   .a 95 to 692 34 to 631       598/631
(94 %)
8 diff
(98.8 %id)
CR985056 T-Lymphocytes .a 105 to 321 1 to 217       217/217
(100 %)
0 diff
(100 %id)
CR985163 T-Lymphocytes .a 108 to 453 1 to 348       348/348
(100 %)
4 diff
(98.9 %id)
TI_59390897   .a 117 to 688 99 to 668       570/570
(100 %)
2 diff
(99.7 %id)
BM020117 astrocytoma grade IV, cell line, brain .a 120 to 688 1 to 567       567/567
(100 %)
2 diff
(99.7 %id)
BG424807 Kidney, renal cell adenocarcinoma .a 146 to 903 8 to 759       752/880
(85 %)
14 diff
(98.5 %id)
BM809880 astrocytoma grade IV, cell line, brain .a 146 to 1126 50 to 1034       985/1127
(87 %)
27 diff
(97.7 %id)
BX350775   .a 148 to 1060 908 to 1       906/908
(99 %)
29 diff
(96.9 %id)
W69598 heart .a 200 to 460 1 to 261       261/262
(99 %)
6 diff
(97.8 %id)
BE615017 adenocarcinoma, Pancreas .a 208 to 989 1 to 777       777/954
(81 %)
22 diff
(97.7 %id)
BE615026 adenocarcinoma, Pancreas .a 208 to 1011 1 to 789       789/931
(84 %)
25 diff
(97.4 %id)
BF968133 adrenal cortex carcinoma, cell line, adrenal gland .a 220 to 1012 1 to 803       803/876
(91 %)
35 diff
(96.1 %id)
BQ674982 epidermoid carcinoma, cell line, salivary gland .a 233 to 1067 1 to 843       843/844
(99 %)
20 diff
(97.7 %id)
BG333060 large cell carcinoma, lung .a 244 to 1022 1 to 780       780/785
(99 %)
16 diff
(98.0 %id)
BI821887 pooled brain, lung, testis .a 271 to 922 253 to 930       676/934
(72 %)
67 diff
(92.9 %id)
EC461697 Prostate .a 322 to 423 1 to 103       103/103
(100 %)
3 diff
(97.1 %id)
CN373368 embryonic stem cells, cell lines H1, H7, andH9 .a 331 to 646 1 to 316       316/316
(100 %)
1 diff
(99.7 %id)
AA410825 ovarian tumor, ovary .a 356 to 832 1 to 478       476/478
(99 %)
14 diff
(97.1 %id)
BG254305 adenocarcinoma, cell line, Prostate .a 383 to 1188 1 to 794       794/905
(87 %)
22 diff
(97.6 %id)
AW842965 colon_normal .a 417 to 536 6 to 127       122/132
(92 %)
6 diff
(95.5 %id)
BX337323 Placenta Cot 25-normalized .a 430 to 945 1 to 516       516/516
(100 %)
7 diff
(98.7 %id)
BM462242 eye, retinoblastoma .a 437 to 1405 1 to 978       978/1108
(88 %)
22 diff
(98.1 %id)
TI_154185924   .a 447 to 1142 121 to 809       689/939
(73 %)
8 diff
(99.2 %id)
CF122221 CNCAP(3)T-225 cell line, Prostate .a 460 to 1182 1 to 724       724/724
(100 %)
11 diff
(98.5 %id)
TI_154181727   .a 467 to 1337 77 to 934       858/861
(99 %)
11 diff
(98.8 %id)
BG820392 anaplastic oligodendroglioma with 1p/19qloss, brain .a 475 to 1130 24 to 684       661/684
(96 %)
18 diff
(97.4 %id)
BI766685 pooled lung and spleen .a 478 to 1136 1 to 659       659/659
(100 %)
0 diff
(100 %id)
TI_57181267   .a 478 to 1136 69 to 727       659/727
(90 %)
6 diff
(99.2 %id)
H91621 liver and spleen .a 495 to 855 1 to 362       362/365
(99 %)
13 diff
(96.5 %id)
BQ335861 marrow .a 500 to 862 371 to 9       363/373
(97 %)
15 diff
(96.0 %id)
BE793575 lung, small cell carcinoma .a 533 to 1386 1 to 833       833/856
(97 %)
34 diff
(96.1 %id)
BI908866 leukocyte .a 544 to 1197 1 to 658       658/660
(99 %)
22 diff
(96.7 %id)
TI_57234713   .a 548 to 1197 39 to 692       655/694
(94 %)
23 diff
(96.7 %id)
BG111756 Bone, osteosarcoma, cell line .a 553 to 1326 1 to 768       768/802
(95 %)
22 diff
(97.3 %id)
BE901540 choriocarcinoma, placenta .a 554 to 1294 1 to 738       738/968
(76 %)
19 diff
(98.1 %id)
BM005990 hepatocellular carcinoma, cell line, Liver .a 574 to 1419 1 to 844       844/845
(99 %)
33 diff
(96.1 %id)
TI_59385941   .a 575 to 1419 95 to 937       843/844
(99 %)
32 diff
(96.3 %id)
BU185009 hepatocellular carcinoma, cell line, Liver .a 576 to 1406 1 to 836       836/1047
(79 %)
14 diff
(98.7 %id)
BG757885 B-cells, primary B-cells from tonsils (cell line) .a 601 to 1366 1 to 759       759/759
(100 %)
10 diff
(98.7 %id)
BG115456 duodenal adenocarcinoma, cell line, small intestine .a 618 to 1400 15 to 784       770/985
(78 %)
22 diff
(97.8 %id)
BG423990 Kidney, renal cell adenocarcinoma .a 633 to 1064 1 to 431       431/431
(100 %)
11 diff
(97.5 %id)
BF343772 brain, glioblastoma with EGFR amplification .a 688 to 1487 1 to 804       804/1054
(76 %)
31 diff
(97.1 %id)
BQ669491 epidermoid carcinoma, cell line, salivary gland .a 691 to 1364 1 to 687       687/993
(69 %)
21 diff
(97.9 %id)
BM705524 eye, fetal eyes .a 721 to 964 1 to 244       244/244
(100 %)
0 diff
(100 %id)
R20597 whole brain .a 734 to 1033 1 to 311     Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 311/356
(87 %)
15 diff
(95.8 %id)
AA024954 heart .a 737 to 1192 1 to 460     Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 460/460
(100 %)
7 diff
(98.5 %id)
BE788396 large cell carcinoma, lung .a 742 to 1287 1 to 545       545/550
(99 %)
7 diff
(98.8 %id)
AL574186 placenta, Placenta Cot 25-normalized .a 747 to 1758 1032 to 21   fully sequenced,   1012/1032
(98 %)
0 diff
(100 %id)
BG403482 bladder, transitional cell papilloma, cell line .a 752 to 1590 1 to 839       839/872
(96 %)
47 diff
(94.7 %id)
BF975500 B-cells, primary B-cells from tonsils (cell line) .a 753 to 1490 1 to 734       734/957
(76 %)
16 diff
(98.4 %id)
Z42847 brain, total brain .a 781 to 1110 1 to 330       330/330
(100 %)
1 diff
(99.7 %id)
H79838 liver and spleen .a 783 to 1200 9 to 429       421/429
(98 %)
5 diff
(98.9 %id)
BX343398 Neuroblastoma Cot 25-normalized .a 786 to 1787 998 to 1       998/1001
(99 %)
14 diff
(98.7 %id)
CN373366 embryonic stem cells, cell lines H1, H7, andH9 .a 791 to 1492 13 to 713       701/713
(98 %)
6 diff
(99.2 %id)
BI084025 epidermoid carcinoma, cell line, salivary gland .a 813 to 1232 1 to 419   fully sequenced,   419/419
(100 %)
2 diff
(99.6 %id)
BX379164 Placenta Cot 25-normalized .a 823 to 1783 958 to 1   fully sequenced,   958/958
(100 %)
13 diff
(98.7 %id)
AL522493 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .a 844 to 1786 943 to 1   fully sequenced,   943/943
(100 %)
11 diff
(98.9 %id)
BI523258 brain .a 868 to 1741 890 to 1   fully sequenced,   890/890
(100 %)
30 diff
(96.7 %id)
TI_44185178   .a 868 to 1741 890 to 1   fully sequenced,   890/890
(100 %)
30 diff
(96.7 %id)
AL522458 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .a 878 to 1794 907 to 1   fully sequenced,   907/907
(100 %)
7 diff
(99.3 %id)
BX395769 Placenta Cot 25-normalized .a 884 to 1768 901 to 16   fully sequenced,   886/901
(98 %)
53 diff
(94.2 %id)
AL516277 brain, neuroblastoma, neuroblastoma cells .a 895 to 1779 891 to 7       885/891
(99 %)
0 diff
(100 %id)
AL581278 B cells (Ramos cell line), B cells from Burkitt lymphoma .a 896 to 1786 883 to 1   fully sequenced,   883/883
(100 %)
7 diff
(99.3 %id)
AL569682 placenta .a 900 to 1721 872 to 52       821/872
(94 %)
0 diff
(100 %id)
AL566252 brain, fetal brain .a 918 to 1715 850 to 57   fully sequenced,   794/850
(93 %)
19 diff
(97.8 %id)
AL563912 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .a 921 to 1786 865 to 1   fully sequenced,   865/865
(100 %)
24 diff
(97.3 %id)
AL536213 brain, fetal brain .a 921 to 1569 790 to 148   fully sequenced,   643/726
(88 %)
17 diff
(97.7 %id)
BX396096 Placenta Cot 25-normalized .a 947 to 1749 796 to 1   fully sequenced,   796/796
(100 %)
8 diff
(99.0 %id)
BX374155   .a 948 to 1811 862 to 1   fully sequenced,   862/862
(100 %)
25 diff
(97.1 %id)
AL580414 T cells from T cell leukemia .a 967 to 1785 813 to 1   fully sequenced,   813/813
(100 %)
11 diff
(98.7 %id)
BX394591 Neuroblastoma Cot 25-normalized .a 976 to 1785 805 to 1   fully sequenced,   805/805
(100 %)
2 diff
(99.8 %id)
AL524976 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 1107 to 1555 681 to 232       450/452
(99 %)
0 diff
(100 %id)
BI084833 epidermoid carcinoma, cell line, salivary gland .a 1202 to 1766 570 to 1   fully sequenced,   570/570
(100 %)
2 diff
(99.7 %id)
BX337322 Placenta Cot 25-normalized .a 1210 to 1764 568 to 16       553/568
(97 %)
0 diff
(100 %id)
BE207461 melanotic melanoma, skin .a 1346 to 1815 480 to 11   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 470/470
(100 %)
0 diff
(100 %id)
H79839 liver and spleen .a 1440 to 1814 377 to 1       377/391
(96 %)
12 diff
(97.0 %id)
H91622 liver and spleen .a 1488 to 1777 290 to 1       290/290
(100 %)
5 diff
(98.3 %id)
W69411 heart .a 1569 to 1689 121 to 1       121/123
(98 %)
0 diff
(100 %id)
AA024955 heart .a 1569 to 1815 262 to 16   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 247/252
(98 %)
1 diff
(99.7 %id)
R46100 whole brain .a 1604 to 1814 231 to 21   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 211/211
(100 %)
3 diff
(98.6 %id)
BG036720 brain, hippocampus .b 1 to 587 1 to 590   tiling clone,   590/759
(77 %)
14 diff
(98.2 %id)
CR615271 Neuroblastoma Cot 25-normalized .b 98 to 1715 1 to 1618   tiling clone,   1618/1618
(100 %)
0 diff
(100 %id)
BX343399 Neuroblastoma Cot 25-normalized .b 98 to 1088 1 to 980       980/1043
(93 %)
30 diff
(97.2 %id)
BX375303 Neuroblastoma Cot 25-normalized .b 98 to 1151 1 to 1049       1049/1060
(98 %)
44 diff
(95.9 %id)
BF966799 brain, hippocampus .b 1314 to 1730 450 to 1   tiling clone,   750/974
(77 %)
33 diff
(96.7 %id)
AL557261 T cells (Jurkat cell line), T cells from T cell leukemia .c 1 to 986 14 to 994   tiling clone,   981/1005
(97 %)
7 diff
(99.4 %id)
AA326568 brain, cerebellum .c 213 to 611 1 to 405   tiling clone,   405/405
(100 %)
12 diff
(97.1 %id)
W07438 lung .c 948 to 1389 1 to 446   tiling clone,   446/449
(99 %)
12 diff
(97.4 %id)
AL579336 T cells (Jurkat cell line), T cells from T cell leukemia .c 1171 to 2062 908 to 29   tiling clone,   880/917
(95 %)
0 diff
(100 %id)
BG820961 anaplastic oligodendroglioma with 1p/19qloss, brain .c 1560 to 2194 1 to 641   tiling clone,   641/800
(80 %)
18 diff
(97.8 %id)
CX872882 embryonic stem .c 1641 to 2194 1 to 554   tiling clone,   554/595
(93 %)
1 diff
(99.9 %id)
N80598 lung .c 1999 to 2199 200 to 1   tiling clone,   200/200
(100 %)
3 diff
(98.5 %id)
BE336717 Kidney, renal cell adenocarcinoma .d 1 to 468 1 to 468   tiling clone,   468/468
(100 %)
0 diff
(100 %id)
BE302484 melanotic melanoma, skin .d 3 to 514 1 to 512     Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 512/512
(100 %)
0 diff
(100 %id)
CR624510 Placenta Cot 25-normalized .d 7 to 1752 1 to 1746   tiling clone,   1746/1746
(100 %)
0 diff
(100 %id)
AW239312 lung, cell line .d 42 to 468 1 to 427     Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 427/427
(100 %)
0 diff
(100 %id)
BF343868 brain, glioblastoma with EGFR amplification .d 773 to 1423 125 to 779       655/858
(76 %)
46 diff
(94.7 %id)
BI918909 brain .d 788 to 1679 3 to 906       904/907
(99 %)
31 diff
(96.6 %id)
TI_57241977   .d 788 to 1679 3 to 906       904/907
(99 %)
31 diff
(96.6 %id)
BI919114 brain .d 792 to 1469 1 to 676       676/676
(100 %)
4 diff
(99.5 %id)
TI_57242060   .d 792 to 1469 1 to 676       676/676
(100 %)
4 diff
(99.5 %id)
BX402086 Neuroblastoma Cot 25-normalized .d 793 to 1743 957 to 7       951/957
(99 %)
0 diff
(100 %id)
BQ434039 embryonal carcinoma, cell line, testis .d 801 to 1539 33 to 778       746/844
(88 %)
17 diff
(98.0 %id)
BX364381   .d 808 to 1754 939 to 1       939/966
(97 %)
19 diff
(98.1 %id)
T54436 placenta .d 828 to 1138 1 to 314     Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 314/320
(98 %)
6 diff
(98.2 %id)
T54437 placenta .d 828 to 1249 1 to 437       437/437
(100 %)
20 diff
(95.5 %id)
BX427452 fetal liver, Liver .d 829 to 1741 906 to 1       906/906
(100 %)
14 diff
(98.5 %id)
BX094770 lung .d 868 to 1438 1 to 570       570/570
(100 %)
1 diff
(99.9 %id)
W07773 lung .d 868 to 1383 1 to 530       530/533
(99 %)
26 diff
(95.2 %id)
BG758812 B-cells, primary B-cells from tonsils (cell line) .d 875 to 1746 1 to 873       873/891
(97 %)
21 diff
(97.7 %id)
BG760027 B-cells, primary B-cells from tonsils (cell line) .d 875 to 1733 1 to 856       856/974
(87 %)
11 diff
(98.9 %id)
TI_154111712   .d 889 to 1783 962 to 77   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 886/953
(92 %)
15 diff
(98.5 %id)
T31845 colon, epididymis .d 903 to 1210 1 to 312       312/312
(100 %)
5 diff
(98.4 %id)
BG506955 lung .d 918 to 1650 1 to 722       722/724
(99 %)
23 diff
(96.9 %id)
BG490306 large cell carcinoma, lung .d 919 to 1656 1 to 736       736/736
(100 %)
6 diff
(99.2 %id)
BU665174 blood .d 925 to 1637 12 to 724       713/724
(98 %)
6 diff
(99.2 %id)
CN373369 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 946 to 1529 8 to 591       584/591
(98 %)
9 diff
(98.5 %id)
CV395584 lung_tumor .d 953 to 1483 14 to 549       536/549
(97 %)
6 diff
(99.0 %id)
TI_149287611   .d 979 to 1782 921 to 111   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 811/1119
(72 %)
43 diff
(96.2 %id)
BE395558 endometrium, adenocarcinoma cell line, uterus .d 997 to 1449 1 to 453       453/454
(99 %)
7 diff
(98.5 %id)
BQ219453 brain .d 1023 to 1730 1 to 725       725/956
(75 %)
20 diff
(98.0 %id)
AA456780 ovarian tumor, ovary .d 1045 to 1494 1 to 450       450/450
(100 %)
0 diff
(100 %id)
CA450068 Human Lung Epithelial cells, lung .d 1045 to 1782 756 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 738/738
(100 %)
1 diff
(99.9 %id)
CN373367 embryonic stem cells, DMSO-treated H9 cellline .d 1063 to 1351 1 to 289       289/289
(100 %)
2 diff
(99.4 %id)
CA308549 Alveolar Macrophage, lung .d 1075 to 1782 726 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 708/708
(100 %)
0 diff
(100 %id)
CA448527 Chondrosarcoma, Left Pelvis .d 1086 to 1783 716 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 698/698
(100 %)
1 diff
(99.9 %id)
BQ015838 lung, Metastatic Chondrosarcoma .d 1090 to 1782 710 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 692/692
(100 %)
1 diff
(99.9 %id)
CB242604 Human Lung Epithelial cells, lung .d 1093 to 1782 709 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 691/691
(100 %)
2 diff
(99.8 %id)
BU607795 Human Lung Epithelial cells, lung .d 1131 to 1782 670 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 652/672
(97 %)
0 diff
(100 %id)
BM711901 eye, human retina .d 1141 to 1782 1 to 638   fully sequenced, Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 638/638
(100 %)
4 diff
(99.4 %id)
R08060 liver and spleen .d 1144 to 1526 1 to 390       390/390
(100 %)
12 diff
(97.0 %id)
BM997816 lung, Lung Focal Fibrosis .d 1149 to 1783 653 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 635/635
(100 %)
2 diff
(99.7 %id)
AL135100 melanoma (MeWo cell line) .d 1155 to 1513 1 to 359       359/359
(100 %)
0 diff
(100 %id)
BF895227 marrow .d 1161 to 1571 1 to 408       408/408
(100 %)
12 diff
(97.1 %id)
BU625008 cell lines, Enchondroma .d 1167 to 1782 634 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 616/616
(100 %)
7 diff
(98.9 %id)
AA431679   .d 1171 to 1628 1 to 458   fully sequenced,   458/458
(100 %)
1 diff
(99.8 %id)
BX338807 Placenta Cot 25-normalized .d 1175 to 1783 1 to 609       609/609
(100 %)
3 diff
(99.6 %id)
BX351953 Placenta Cot 25-normalized .d 1175 to 1774 600 to 5       596/600
(99 %)
0 diff
(100 %id)
BX338806 Placenta Cot 25-normalized .d 1178 to 1752 579 to 1       579/582
(99 %)
0 diff
(100 %id)
BU622888 cell lines, Enchondroma .d 1186 to 1782 614 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 596/596
(100 %)
3 diff
(99.5 %id)
BE737068 adenocarcinoma, Pancreas .d 1194 to 1578 38 to 422       385/677
(56 %)
5 diff
(99.3 %id)
BX392221 Neuroblastoma Cot 25-normalized .d 1214 to 1732 520 to 1       520/677
(76 %)
14 diff
(98.0 %id)
TI_159717841   .d 1217 to 1782 686 to 121   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 566/989
(57 %)
0 diff
(100 %id)
CB852626 Human Lung Epithelial cells, lung .d 1217 to 1782 639 to 74   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 566/576
(98 %)
0 diff
(100 %id)
CT003734 T-Lymphocytes .d 1241 to 1783 1 to 543   tiling clone, AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 543/543
(100 %)
0 diff
(100 %id)
CA424549 cell lines, Chondrosarcoma .d 1242 to 1783 560 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 542/542
(100 %)
3 diff
(99.5 %id)
T83315 liver and spleen .d 1253 to 1450 1 to 199   fully sequenced, Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 199/199
(100 %)
6 diff
(97.0 %id)
BF806146 colon_ins .d 1257 to 1365 1 to 109       109/110
(99 %)
3 diff
(97.3 %id)
DB540219 hippocampus .d 1259 to 1781 1 to 523     Submitted on the opposite strand 523/523
(100 %)
8 diff
(98.5 %id)
BX414393 fetal liver, Liver .d 1300 to 1734 436 to 1       436/436
(100 %)
38 diff
(91.3 %id)
BE206184 Kidney, renal cell adenocarcinoma .d 1304 to 1783 487 to 8       480/487
(98 %)
0 diff
(100 %id)
CA428780 Cell Line, Chondrosarcoma .d 1310 to 1782 492 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 474/474
(100 %)
2 diff
(99.6 %id)
BU734815 eye, lens .d 1311 to 1783 491 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 473/473
(100 %)
2 diff
(99.6 %id)
AI799254 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .d 1320 to 1782 466 to 4       463/466
(99 %)
0 diff
(100 %id)
BE855627 brain, glioblastoma (pooled) .d 1320 to 1783 464 to 1       464/464
(100 %)
0 diff
(100 %id)
AK000263 colon mucosa .d 1323 to 1783 1 to 461   available from FLJ, AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 461/461
(100 %)
1 diff
(99.8 %id)
BP224305 colon mucosa .d 1324 to 1631 1 to 308       308/315
(97 %)
2 diff
(99.4 %id)
AW338632 adenocarcinoma, Pancreas .d 1325 to 1782 466 to 9       458/466
(98 %)
0 diff
(100 %id)
AI341718   .d 1344 to 1782 454 to 15   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 440/440
(100 %)
13 diff
(97.1 %id)
AW293724   .d 1363 to 1781 436 to 18   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 419/419
(100 %)
1 diff
(99.8 %id)
R37398 whole brain .d 1365 to 1782 442 to 21   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 422/462
(91 %)
20 diff
(95.7 %id)
AA633144 colon, colon tumor RER+ .d 1368 to 1782 430 to 17   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 414/414
(100 %)
2 diff
(99.6 %id)
EC530631 Prostate .d 1372 to 1470 1 to 99       99/103
(96 %)
5 diff
(95.2 %id)
BP382653 adipose tissue .d 1373 to 1778 1 to 406       406/592
(68 %)
9 diff
(98.5 %id)
AK024622 adipose tissue .d 1373 to 1783 1 to 411   available from FLJ, AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 411/411
(100 %)
3 diff
(99.3 %id)
EC584377 Prostate .d 1375 to 1476 1 to 102       102/102
(100 %)
3 diff
(97.1 %id)
AA628561   .d 1379 to 1782 408 to 5       404/408
(99 %)
0 diff
(100 %id)
TI_153988125   .d 1392 to 1781 508 to 119   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 390/392
(99 %)
5 diff
(98.8 %id)
AI934784 anaplastic oligodendroglioma, brain .d 1393 to 1782 390 to 1       390/390
(100 %)
0 diff
(100 %id)
N80711 lung .d 1398 to 1782 390 to 3       388/390
(99 %)
0 diff
(100 %id)
AA046148 uterus .d 1409 to 1655 1 to 249   fully sequenced,   249/249
(100 %)
1 diff
(99.6 %id)
AI352087   .d 1413 to 1782 375 to 6       370/375
(98 %)
0 diff
(100 %id)
T90907 liver and spleen .d 1420 to 1782 383 to 20   fully sequenced, AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 364/364
(100 %)
8 diff
(97.9 %id)
BE536592 cervix .d 1420 to 1782 1 to 362       362/611
(59 %)
3 diff
(99.6 %id)
AI984729 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .d 1422 to 1782 377 to 17   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 361/361
(100 %)
18 diff
(95.1 %id)
AW087845 lung, cell line .d 1424 to 1782 389 to 29   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 361/361
(100 %)
24 diff
(93.4 %id)
AI888619 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .d 1436 to 1782 370 to 24   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 347/347
(100 %)
6 diff
(98.3 %id)
AW204459   .d 1436 to 1781 363 to 18   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 346/346
(100 %)
1 diff
(99.8 %id)
H42420 breast .d 1438 to 1754 324 to 1       324/324
(100 %)
11 diff
(96.7 %id)
AA911094 pooled germ cell tumors .d 1438 to 1782 351 to 7       345/351
(98 %)
0 diff
(100 %id)
T54487 placenta .d 1440 to 1782 364 to 22   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 343/343
(100 %)
7 diff
(98.0 %id)
AI085681 senescent fibroblast .d 1460 to 1782 340 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 322/322
(100 %)
3 diff
(99.1 %id)
T67254 liver and spleen .d 1471 to 1782 322 to 13   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 310/310
(100 %)
4 diff
(98.8 %id)
BE894265 melanotic melanoma, skin .d 1498 to 1777 1 to 280   AAA   280/285
(98 %)
2 diff
(99.3 %id)
AA761361 germinal center B cell .d 1506 to 1782 322 to 47   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 276/276
(100 %)
4 diff
(98.6 %id)
N56266   .d 1510 to 1727 1 to 217       217/217
(100 %)
7 diff
(96.8 %id)
AW026192 brain, glioblastoma (pooled) .d 1512 to 1782 278 to 8       271/278
(97 %)
0 diff
(100 %id)
BE207399 melanotic melanoma, skin .d 1524 to 1783 270 to 11   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 260/260
(100 %)
0 diff
(100 %id)
AA541687 normal prostate, Prostate .d 1537 to 1782 251 to 7       245/251
(97 %)
0 diff
(100 %id)
AI919318 Prostate .d 1543 to 1782 246 to 8       239/255
(93 %)
0 diff
(100 %id)
BF590965 colon, colon tumor, RER+ .d 1550 to 1783 244 to 11   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 234/234
(100 %)
3 diff
(98.8 %id)
BQ637139 eye, retina .d 1552 to 1783 1 to 232   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 232/232
(100 %)
0 diff
(100 %id)
AA659821 normal prostate, Prostate .d 1556 to 1782 230 to 4       227/230
(98 %)
0 diff
(100 %id)
AI560320 anaplastic oligodendroglioma, brain .d 1607 to 1782 177 to 1       177/178
(99 %)
1 diff
(99.5 %id)
AA431476   .d 1618 to 1771 154 to 1   fully sequenced,   154/154
(100 %)
0 diff
(100 %id)
AA046038 uterus .d 1625 to 1782 159 to 1   fully sequenced,   159/159
(100 %)
1 diff
(99.4 %id)
EC542476 Prostate .d 1639 to 1738 1 to 100       100/100
(100 %)
0 diff
(100 %id)
BM665704 eye, human retina .d 1726 to 1781 75 to 20   fully sequenced, AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 56/56
(100 %)
0 diff
(100 %id)
DA633812 Kidney .e 1 to 536 2 to 536   tiling clone, capped   535/535
(100 %)
1 diff
(99.9 %id)
DB320953 Kidney .e 1097 to 1672 576 to 1   tiling clone,   576/576
(100 %)
3 diff
(99.5 %id)
BG910760 anaplastic oligodendroglioma with 1p/19qloss, brain .f 1 to 730 1 to 737   tiling clone,   737/950
(77 %)
28 diff
(97.1 %id)
TI_159677792   .f 148 to 1079 49 to 975 A40P Y41I T42H R44A E45S ... tiling clone,   927/1075
(86 %)
15 diff
(98.7 %id)
CF132063 Chondrosarcoma Lung Metastasis cell lines, lung .f 150 to 969 1 to 818   tiling clone,   818/818
(100 %)
3 diff
(99.7 %id)
BM693874 eye, lens .f 293 to 776 1 to 484   tiling clone, Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 484/484
(100 %)
1 diff
(99.8 %id)
BM670936 eye, lens .f 1456 to 1989 552 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 534/534
(100 %)
9 diff
(98.4 %id)
BM829327 Ascites, stomach .g 1 to 536 1 to 536   tiling clone,   536/536
(100 %)
3 diff
(99.5 %id)
CR616128 Neuroblastoma Cot 10-normalized .g 10 to 1653 1 to 1644 exact tiling clone,   1644/1644
(100 %)
0 diff
(100 %id)
AL521877 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .g 25 to 911 14 to 897 S61T R62A I63S M65W E66K ... fully sequenced,   884/897
(98 %)
4 diff
(99.6 %id)
AL521876 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .g 881 to 1653 768 to 1   fully sequenced,   768/768
(100 %)
4 diff
(99.5 %id)
BQ188235 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .h 1 to 536 1 to 536 V2C L41X P42T G43W A44S ... tiling clone, AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 536/536
(100 %)
5 diff
(99.1 %id)
CN373361 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .i 1 to 704 1 to 704 E2G A80T tiling clone,   704/704
(100 %)
6 diff
(99.2 %id)
AW579477 denis_drash .i 554 to 805 1 to 251   tiling clone,   251/252
(99 %)
5 diff
(98.1 %id)
BI545613 brain, hippocampus .j 1 to 831 1 to 830 exact tiling clone,   830/937
(88 %)
30 diff
(96.8 %id)
TI_44165693   .j 6 to 831 153 to 977       824/1084
(76 %)
38 diff
(96.5 %id)
CA393951 eye, RPE/choroid .j 220 to 719 1 to 500   tiling clone,   500/500
(100 %)
1 diff
(99.8 %id)
AI375989   Gene C19orf22, variant not shown       AAA Suspected internal deletion, this clone was ignored    
AI802434   Gene C19orf22, variant not shown       AAA Suspected internal deletion, this clone was ignored    
BI770971 pooled lung and spleen Gene C19orf22, variant not shown         This clone was ignored    
BI914611 brain Gene C19orf22, variant not shown         This clone was ignored    
TI_57179632   Gene C19orf22, variant not shown         This clone was ignored    
TI_57240886   Gene C19orf22, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C